Ultragenyx Pharmaceutical Inc.
RARE
31 insider filings · Latest: Jun 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 12:06 AM | Emil D KakkisDirector, President & CEO | Sale | 54,404 | $22.80 | $1.2M | 658,994(D) | View → |
| Mar 2, 2026 | Mar 3 11:51 PM | Karah Herdman ParschauerEVP and Chief Legal Officer | Sale | 8,135 | $22.80 | $185.5K | 76,346(D) | View → |
| Mar 2, 2026 | Mar 3 11:51 PM | Theodore Alan HuizengaSVP, Chief Accounting Officer | Sale | 1,632 | $22.80 | $37.2K | 48,670(D) | View → |
| Mar 3, 2026 | Mar 3 11:50 PM | Howard HornChief Financial Officer | Sale | 1,635 | $22.40 | $36.6K | 85,034(D) | View → |
| Mar 2, 2026 | Mar 3 11:50 PM | Howard HornChief Financial Officer | Sale | 8,409 | $22.70 | $190.9K | 86,669(D) | View → |
| Mar 2, 2026 | Mar 3 11:49 PM | Eric CrombezEVP and Chief Medical Officer | Sale | 7,029 | $22.80 | $160.3K | 76,301(D) | View → |
| Mar 3, 2026 | Mar 3 9:41 PM | HOWARD HORN | Proposed Sale | 1,635 | $22.40 | $36.6K | — | View → |
| Mar 2, 2026 | Mar 2 10:08 PM | HOWARD HORN | Proposed Sale | 3,119 | $22.54 | $70.3K | — | View → |
| Feb 2, 2026 | Feb 3 5:00 PM | Howard HornChief Financial Officer | Sale | 3,061 | $23.56 | $72.1K | 88,935(D) | View → |
| Feb 2, 2026 | Feb 2 9:09 PM | HOWARD HORN | Proposed Sale | 3,061 | $23.56 | $72.1K | — | View → |
| Jan 2, 2026 | Jan 2 9:10 PM | HOWARD HORN | Proposed Sale | 3,150 | $22.84 | $71.9K | — | View → |
| Dec 10, 2025 | Dec 10 9:05 PM | HOWARD HORN | Proposed Sale | 3,081 | $36.38 | $112.1K | — | View → |
| Sep 12, 2025 | Sep 12 8:17 PM | KARAH PARSCHAUER | Proposed Sale | 2,450 | $31.17 | $76.4K | — | View → |
| Jun 20, 2025 | Jun 20 8:02 PM | CORAZON D. SANDERS | Proposed Sale | 2,405 | $37.39 | $89.9K | — | View → |
| Feb 28, 2025 | Feb 28 9:11 PM | KAKKIS EMIL D | Proposed Sale | 25,000 | $42.48 | $1.1M | — | View → |
| Feb 27, 2025 | Feb 27 10:08 PM | Parschauer Karah Herdman | Proposed Sale | 2,990 | $42.88 | $128.2K | — | View → |
| Dec 30, 2024 | Dec 30 9:32 PM | KAKKIS EMIL D | Proposed Sale | 11,727 | $42.23 | $495.3K | — | View → |
| Dec 10, 2024 | Dec 10 9:12 PM | KAKKIS EMIL D | Proposed Sale | 8,273 | $50.00 | $413.6K | — | View → |
| Sep 3, 2024 | — | KAKKIS EMIL D | Proposed Sale | 20,000 | $55.85 | $1.1M | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | May 18 10:50 PM | Matthew K FustDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:41 PM | Shehnaaz SulimanDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:39 PM | Amrit RayDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:38 PM | Corazon (Corsee) D. SandersDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:35 PM | Michael NarachiDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:23 PM | Daniel G WelchDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:21 PM | Deborah DunsireDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| Apr 22, 2026 | Apr 24 8:39 PM | Theodore Alan HuizengaSVP, Chief Accounting Officer | Grant/Award | 7,348 | $24.61 | 7,348(D) | View → |
| Apr 16, 2026 | Apr 20 9:19 PM | Emil D KakkisDirector, President & CEO | Grant/Award | 132,693 | $24.52 | 132,693(D) | View → |
| Apr 16, 2026 | Apr 20 9:17 PM | Dennis Karl HuangEVP, Chief Technical Operations Officer | Grant/Award | 79,936 | $24.52 | 79,936(D) | View → |
| Apr 16, 2026 | Apr 20 9:16 PM | John Richard PinionEVP, Chief Quality Operations Officer | Grant/Award | 79,936 | $24.52 | 79,936(D) | View → |
| Apr 16, 2026 | Apr 20 9:15 PM | Karah Herdman ParschauerEVP and Chief Legal Officer | Grant/Award | 49,960 | $24.52 | 49,960(D) | View → |
| Apr 16, 2026 | Apr 20 9:13 PM | Erik HarrisEVP & Chief Commercial Officer | Grant/Award | 49,960 | $24.52 | 49,960(D) | View → |
| Apr 16, 2026 | Apr 20 9:11 PM | Eric CrombezEVP and Chief Medical Officer | Grant/Award | 59,952 | $24.52 | 59,952(D) | View → |
| Apr 16, 2026 | Apr 20 9:09 PM | Howard HornChief Financial Officer | Grant/Award | 59,952 | $24.52 | 59,952(D) | View → |